New Stock News | Robotechnik Intelligent Technology (03757) IPO Subscription Closes; Margin Subscription Amount Approximately HK$3.593 Billion, 5.93 Times Oversubscribed
Robotechnik Intelligent Technology (03757) opened its IPO for subscription from September 21 to 24. Subscription has now closed, and the shares will be listed and traded on the Hong Kong Stock Exchange on September 29.
Robotechnik Intelligent Technology (03757) opened its IPO for subscription from September 21 to 24. The subscription period has now closed, and the shares will be listed and traded on HKEX on September 29. As of noon on September 24, based on the public offering amount of HK$517.79 million, Robotechnik Intelligent Technology's margin subscription amount was approximately HK$3.593 billion, representing an oversubscription of 5.93 times.
The company's IPO plan intends to globally offer 11.876 million H shares, with approximately 10% under the Hong Kong public offering and approximately 90% under the international offering, plus an approximately 15% over-allotment option. The offer price will not exceed HK$436 per offer share, with a board lot of 50 shares. Citi, Huatai International, and Orient International are its joint sponsors.
Robotechnik Intelligent Technology is a global supplier of manufacturing equipment and systems for the photovoltaic industry and the silicon photonics industry. The company's photovoltaic manufacturing solutions include (i) photovoltaic manufacturing equipment, mainly automation equipment used in photovoltaic cell production, performing functions such as silicon wafer loading and unloading; (ii) complete production lines, in which the company integrates its own equipment with equipment procured from third-party suppliers as needed, together with related design, configuration, and installation services, to provide complete solutions tailored to customers' specific needs; and (iii) intelligent manufacturing systems, a software-centric solution built around the company's proprietary R2FabMES platform to enable automated factory operations at customers' production facilities.
According to CIC data, based on 2025 revenue, the company ranked fifth globally in the intelligent photovoltaic cell automated manufacturing equipment sector, with a market share of 2.6%, and based on 2025 revenue, ranked first globally in the silicon photonics intelligent manufacturing equipment sector, with a market share of 20.5%.
Robotechnik Intelligent Technology's 2026 semi-annual report shows that during the reporting period, the company achieved operating revenue of RMB 608 million, a year-on-year increase of 144.82%. It achieved net profit attributable to shareholders of the listed company of RMB 6.5568 million. It achieved net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses of RMB 3.8804 million. As of the date of the report disclosure, the amount of orders in hand for which revenue had not yet been recognized was approximately RMB 3.386 billion.
Regarding the use of proceeds, among the net proceeds from the global offering (assuming the over-allotment option and the offer size adjustment right are not exercised), approximately 20.0% will be used to strengthen product and technology research and development and innovation; approximately 40.0% will be used to expand production capacity and improve delivery speed; approximately 10.0% will be used to establish a global sales and service network; approximately 20.0% will be used for strategic investments and/or acquisitions; and approximately 10.0% will be used as working capital and for other general corporate purposes.
In addition, the company has entered into cornerstone investment agreements with cornerstone investors, pursuant to which the cornerstone investors have agreed, subject to certain conditions, to subscribe for or procure their designated entities to subscribe for the relevant number of offer shares that can be purchased for an aggregate amount of approximately US$232.4 million at the offer price.
The company's cornerstone investors include: Temasek Holdings (Private) Limited, Shengtian Industrial Group (Hong Kong) Limited, Ivy Asset Management (Hong Kong) Limited, E Fund Management Co., Ltd., E Fund Management (Hong Kong) Co., Limited, Shanghai Cig Shanghai Co., Ltd., Victory Privilege Fund OFC-Winner Global Fund, Wind Sabre Fund SPC, Chengheng International Group Limited, Arrowpoint Master Fund, Stable Growth Fund SP, Lu Hua Asset Management Limited, Bloom Capital Limited, Mr. Lai Pak Lam, Mr. Xia Shengli, Mr. Zhu Guodong, and Mr. Zheng Xiaofeng.
Related Articles

Shenzhen Lifotronic Technology Co., Ltd. (688389.SH): H100Plus Hemoglobin Testing System Receives U.S. FDA 510(k) Clearance

LIANLIAN (02598) repurchased 90,500 shares for approximately HK$299,400 on October 8.

CHINANEWENERGY (01156): Zhang Junting has been appointed as an independent non-executive director.
Shenzhen Lifotronic Technology Co., Ltd. (688389.SH): H100Plus Hemoglobin Testing System Receives U.S. FDA 510(k) Clearance

LIANLIAN (02598) repurchased 90,500 shares for approximately HK$299,400 on October 8.

CHINANEWENERGY (01156): Zhang Junting has been appointed as an independent non-executive director.






